Case study: Bringing next-generation visual field testing to clinics across Germany

In Germany’s rapidly evolving ophthalmic landscape, innovation is essential to meet growing clinical demands and the needs of an aging population. With more than 8,000 practicing ophthalmologists and a strong tradition of excellence in diagnostics and research, the German market has long been at the forefront of adopting technologies that improve both efficiency and patient experience.

At the heart of this transformation stands Alpha Eyes GmbH, a German and Austrian-based leader in ophthalmic diagnostics.

"The company is located near Regensburg, or you could say in the Munich region. We also work with many Austrian doctors.” says Klaus Sprenger, CEO of Alpha Eyes.

The company is well-known for its expertise in visual field testing but also distributes high-end imaging and diagnostic platforms, for example the DREAM OCT™ swept-source OCT from Intalight, a next-gen ultra-wide-field device, and intelligent workflow and screening software solutions from partners like RETeval and talkingeyes. Their portfolio therefore spans sophisticated imaging, diagnostics and practice-workflow optimisation, all underpinned by clinically validated technologies that support today’s eye-care professionals.

True to its mission of driving meaningful innovation in eye care, Alpha Eyes partnered with PeriVision, a Swiss medtech company developing digital eye diagnostics powered by AI and virtual reality. Together, they are redefining the standard of visual field testing through VisionOne™, the first VR-based visual field testing platform designed for both clinical precision and patient comfort.

"With VisionOne™, we are giving clinics a tool that simplifies their daily routines while maintaining the diagnostic quality they rely on. It combines precision, comfort, and efficiency in a way that benefits both doctors and patients." Klaus Sprenger

Since introducing VisionOne™ to the German market, Alpha Eyes has seen remarkable adoption and strong engagement from clinics across the country. Doctors and technicians are increasingly recognizing that digital, portable, and patient-friendly testing not only improves the clinical experience but also streamlines day-to-day practice management.

As one of Germany’s key players in ophthalmic innovation, Alpha Eyes is demonstrating how technology and clinical excellence can go hand in hand.

Challenge: Traditional perimetry limiting efficiency and patient comfort

Before the introduction of VisionOne™, most German ophthalmology practices relied on conventional perimetry systems for glaucoma and visual field testing. While these systems remain a gold standard, they also present significant challenges in terms of workflow, space, and patient comfort.

"As clinics looked to modernize, Alpha Eyes saw an opportunity to address these pain points with a more flexible and patient-friendly approach."

Doctors and clinic staff repeatedly pointed to the same issues. Perimetry tests required a darkened room and a dedicated technician to supervise each session. The equipment was large, stationary, and difficult to move, which restricted how many patients could be tested in a single day.

Patients often found the experience tiring and uncomfortable, especially when required to cover one eye or sit still for long periods of time. This fatigue frequently led to unreliable results and, in some cases, the need for retesting. Clinics also faced the added difficulty of integrating test results into their electronic health record systems, slowing down reporting and data management.

For clinics focused on precision and patient comfort, these limitations became increasingly visible. German eye care professionals were looking for a solution that would allow them to maintain the same diagnostic reliability while improving both the patient experience and the overall workflow.

They needed a tool that was faster, more flexible, and more intuitive, one that could meet the realities of modern clinical practice without compromising accuracy.

Solution: Setting a new standard in visual field testing with VisionOne™ in Germany

To address these challenges, Alpha Eyes introduced VisionOne™ by PeriVision, a Class IIa CE-marked medical device that brings visual field testing into the digital age. Using virtual reality and adaptive algorithms, VisionOne™ delivers reliable, patient-centered results validated in multiple studies demonstrating equivalence with conventional perimetry for glaucoma and retinal diseases.

Unlike traditional bowl perimeters, VisionOne™ is portable, intuitive, and requires no dark room or complex setup. Its adaptive software automatically adjusts to the patient’s pace and response, improving both comfort and data quality.

“Patients can keep their glasses on, there’s no eye patch or dark room, and the headset gently guides them through each step,” explains Sprenger. “That makes testing faster and more comfortable while maintaining full diagnostic accuracy.”

Clinics report shorter test times, seamless EHR integration, and smoother workflows, freeing up staff to focus more on patient interaction. Certified under FDA, CE, and MHRA standards, VisionOne™ delivers medical-grade precision with a user-friendly design that patients describe as comfortable, engaging, and stress-free.

By combining clinical reliability with human-centered design, VisionOne™ is redefining how German eye clinics conduct visual field testing: faster, smarter, and more accessible than ever.

Results: Strong adoption and measurable impact across German clinics

Since its introduction, VisionOne™ has achieved outstanding success across Germany. Alpha Eyes is now an important partner in VisionOne™ sales, a reflection of both the trust it has earned from German eye care professionals and the tangible benefits the device brings to everyday practice.

“We’ve seen clinics transition entire workflows to VisionOne™ within weeks,” notes Sprenger. “The difference in efficiency and patient engagement is tangible from day one.”

Feedback from clinics across Germany has been highly encouraging. Doctors highlight the shorter test duration, ease of use, and the positive response from patients as key factors driving adoption.

Patients consistently describe the test as more natural, less tiring, and even enjoyable compared to conventional perimetry. This higher comfort level increases cooperation and improves data reliability, leading to better care outcomes.

The partnership has also strengthened relationships with leading ophthalmology centers, where VisionOne™ is now part of routine clinical workflows. For Alpha Eyes, the success of VisionOne™ represents more than a commercial achievement. It is a testament to how meaningful innovation can reshape a field as established as visual field testing. By introducing a technology that simplifies workflows, empowers clinicians, and enhances patient care, Alpha Eyes has reinforced its position as a trusted partner for digital transformation in ophthalmology.

Today, the company continues to expand its partnerships with clinics and hospitals across Germany, supporting the transition toward smarter, more connected, and more patient-centered eye care.

Together, Alpha Eyes and PeriVision are defining the next era of visual field testing, combining innovation, precision, and patient focus to change how clinicians prevent vision loss and deliver care across Germany and beyond.

Discover VisionOne™ in action